Single-Port Access Laparoscopic Surgery in Gynecologic Oncology: Outcomes and Feasibility

Figurelli, Justine; Bresson, Lucie; Narducci, Fabrice; Katdare, Ninad; Coulon, Pascale; Fournier, Charles; Leblanc, Éric

doi:10.1097/igc.0000000000000150

Cited by 12 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many studies have compared open surgery and laparoscopic surgery in gynecology. Furthermore, several studies have compared conventional laparoscopy using multiple ports and laparotomy in ovarian cancer [9,18,[19][20][21]. However, no previous study has compared single-port laparoscopic surgery and laparotomy in ovarian cancer, although several studies have compared single-port and multiport laparoscopic surgery for benign gynecologic diseases [13,22].…”

Section: Discussionmentioning

confidence: 99%

Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging

et al. 2021

View full text Add to dashboard Cite

Objectives The aims of this study were to assess the feasibility of single-port laparoscopic surgical staging (SPLS) in early ovarian cancer and to compare the surgical outcomes of SPLS with those of staging laparotomy. Methods Between January 2014 and December 2018, 40 patients underwent SPLS and 41 patients underwent staging laparotomy at Yonsei Cancer Center. The patients were diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage I ovarian cancer. Variables such as patient age, body mass index (BMI), tumor size, FIGO stage, and perioperative surgical outcomes and survival outcomes of SPLS and laparotomy were compared. Results The total operation time was similar between the 2 groups (SPLS: 201.4 vs. laparotomy: 203.0 minutes, P =0.806). The median tumor diameters in the SPLS and laparotomy groups were 11.0 (2.5–28 cm) and 15.4 (6–40 cm), respectively ( P =0.001). The SPLS group had lower tumor spillage rate (5.0% vs. 19.5%, P =0.047), less intraoperative blood loss (102.0 vs. 371.5 mL, P <0.001), less postoperative pain, and shorter postoperative hospital stay (5 vs. 9.5 days, P <0.001). The intraoperative major complication rate was similar between groups (2.5% vs. 4.9%, P =0.571). There was no significant difference in progression-free survival between the 2 groups ( P =0.945). There were no deaths in either group. Conclusion SPLS is feasible in early ovarian cancer and has better perioperative surgical outcomes, in some aspects, than staging laparotomy without compromising survival outcomes. SPLS could be performed in patients suspected to have early ovarian cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging

et al. 2021

View full text Add to dashboard Cite

show abstract

“…As the incision is created in the umbilicus, the surgical scar is concealed, providing aesthetic superiority. Numerous studies have analyzed the safety and effectiveness of LESS, and this technique is used not only for benign adnexal surgeries but also for hysterectomies and cancer surgeries [20,21]. Most of the gynecologic surgeries performed in the Department of Obstetrics and Gynecology, National Health Insurance Service Ilsan Hospital are conducted with a standardized procedure of LESS or robotassisted LESS (DaVinci Xi System).…”

Section: Discussionmentioning

confidence: 99%

The role of port site local anesthetic injection in laparoendoscopic single site surgery: a prospective randomized study

et al. 2020

View full text Add to dashboard Cite

Objective To investigate the role of port-site bupivacaine hydrochloride injection in laparoendoscopic single-site surgery (LESS) as a means of postoperative umbilical pain alleviation. Methods A total of 200 consecutive patients who underwent LESS from October 2018 to February 2019 were included in this randomized prospective case control study. The patients were alternatively assigned to either the study group (0.25% 10-mL bupivacaine hydrochloride injection at the 1.5-cm umbilical incision site after surgery) or the control group (no injection). All patients underwent surgery at the National Health Insurance Service Ilsan Hospital under the same operational setting by 3 board-certified gynecologists. Postoperative umbilical pain scores assessed using the visual analog scale were compared between the 2 groups as the primary outcome. Student's t-test, χ 2 test, and a linear mixed model were used for the statistical analysis. A P-value of <0.05 was considered to be statistically significant. Results The patients' age, body mass index, and menopausal status; type of surgery performed; and need for additional trocar insertion exhibited a significant difference between the bupivacaine injection and non-injection groups. After adjusting for various confounding variables, the postoperative umbilical pain scores measured at postoperative 2-3 hours, 6-10 hours, 1 day, and 3 days did not exhibit a significant difference between the 2 groups. Conclusion Port-site bupivacaine injection in LESS did not show any additive effect in alleviation of postoperative umbilical pain.

show abstract

“…32 and both of which concluded that the hospital stay was shortened and the technique was useful. 32,33 Results of our myoma retrieval study Tumor weights, retrieval times, and collection efficiency rates obtained during our study of myoma retrieval techniques used during RPS are shown per retrieval method in Table 1.…”

Section: A C C E P T E D Accepted Manuscriptmentioning

confidence: 99%

Reduced-port surgery in gynecologic fields

Kikuchi

Kumakiri

Aoki

et al. 2015

Gynecology and Minimally Invasive Therapy

View full text Add to dashboard Cite

Reduced-port surgery (RPS) is widely used for various abdominal surgeries. Herein, we review RPS as it applies specifically to the field of obstetrics and gynecology with a view toward its usefulness and future prospects. Because an advisory was issued by the US FDA in May 2014 and sales of the Johnson & Johnson Morcellex devices were subsequently discontinued, a great number of institutions will be forced to see alternative methods of morcellation. Thus, we also approach the question of specimen retrieval during myomectomy.When RPS, including single-port surgery, is performed by a competent surgeon for established indications, it is superior to conventional laparoscopic surgery in terms of the cosmetic outcome, and it can reduce pain and shorten the hospital stay. Ligature manipulations can be problematic, but sealing devices are useful for performing total hysterectomy and adnexectomy without ligature. Furthermore, by using a single-port technique when it is possible to extend the umbilical incision, manual tissue morcellation is facilitated.

show abstract

Single-Port Access Laparoscopic Surgery in Gynecologic Oncology: Outcomes and Feasibility

Abstract: Our experience demonstrates that SPALS is feasible and safe for simple gynecological procedures. This approach may result in a smooth postoperative course and shorter hospital stay and can thus be promoted to a day care procedure.

Cited by 12 publications

References 17 publications

Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging

Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging

The role of port site local anesthetic injection in laparoendoscopic single site surgery: a prospective randomized study

Reduced-port surgery in gynecologic fields

Contact Info

Product

Resources

About